Executive Summary

The Protein Supplement Market stood at 30.3 USD Billion in 2025 and is set to reach 67.2 USD Billion by 2035, a CAGR of 8.3% across the forecast period.

Fitness participation and demand for convenient high-protein diets underpin this trajectory, in line with FAO and FAOSTAT per-capita protein consumption trends. Urbanizing middle-class populations across China, India, Vietnam and Indonesia are lifting per-capita protein-supplement spending in Asia-Pacific and widening the SKU range carried by regional retailers.

North America held 62.25% share in 2025 on established fitness culture, omnichannel retail and an FDA labelling and nutrition-facts framework that supports protein-content claims on pack. Asia-Pacific is projected to grow fastest at a 9.72% CAGR through 2031. Animal-based sources, led by whey protein, and sports nutrition remain the dominant segments; whey and dairy-derived SKUs sold into the US market are manufactured under FDA Food Safety Modernization Act preventive-controls rules and HACCP-based process control, while formats bound for Europe must meet EU Regulation 1169/2011 food-information requirements.

Health-claim compliance costs under EFSA nutrient and claim standards, including EFSA novel-food authorisation requirements that apply to newer protein sources entering the region, alongside dairy input-cost volatility, temper margins in Europe. The competitive base is moderately consolidated. Established sports-nutrition brands compete against plant-protein and clinical-nutrition entrants that lean on USDA Organic and EU organic certification, benchmarked against Codex Alimentarius quality standards, to support premium positioning across channels.

Key Takeaways

• From USD 30.27 Billion in 2025, the market reaches USD 67.19 Billion by 2035 at 8.3% a year.
• Animal-based is the largest protein source category.
• On application, the leading category is Sports nutrition.
• The largest region is North America, at 62.2% in 2025.
• Asia-Pacific is the fastest-growing region through 2035.
• The report profiles 10 suppliers across a moderately-consolidated field.

Market Definition and Scope

The Protein Supplement Market covers powder, ready-to-drink and bar formats built on animal-based proteins (whey, casein, egg, collagen, milk), plant-based proteins (soy, pea, rice, hemp, wheat) and emerging sources (insect, algae, blended), sold for sports nutrition, weight management, clinical nutrition and general wellness through supermarkets, specialty retail, e-commerce and foodservice channels.

Excluded are whole-food protein sources such as meat, dairy and legumes, single-ingredient performance aids like creatine and BCAAs, infant formula, and prescription pharmaceuticals, all of which sit in adjacent categories with distinct regulatory and retail pathways.

Market Trends

Novel Protein Sources Are Advancing Through EFSA’s Novel-Food Approval Pathway

Insect, algae and blended proteins are moving from niche formulation into mainstream SKUs as brands diversify beyond whey and soy. Within the European Union, insect and algae protein require authorization under the EFSA novel-food framework before sale, a step that lengthens launch timelines but clears the ingredient for EU-wide distribution once granted. Packaging for these SKUs must still meet EU Regulation 1169/2011 on food information to consumers, which governs allergen declaration and nutrient labelling regardless of how novel the protein source is. Formulators are also weighing Codex standards on protein identity and labelling as they position blended sources for export markets outside the EU, building a pipeline of differentiated, allergen-light products through 2035. Soy- and pea-based components in these blends fall under the EU’s deforestation regulation, EUDR, pushing formulators toward traceable, deforestation-free sourcing contracts with upstream growers.

Protein Supplementation Is Expanding From Sports Nutrition Into Healthy Aging and Immunity

Demand is broadening beyond gym-goers as general-wellness applications, including immunity support and healthy aging, draw on the same whey, collagen and pea-protein bases used in sports formulations. In the United States, this SKU expansion still sits inside FDA labelling and nutrition-facts rules, which constrain the structure/function claims brands can print on general-wellness packaging relative to sports-specific formats. Clinical nutrition, spanning oral nutritional supplements, enteral and parenteral formats, is following a parallel path as protein intake becomes routine in recovery and geriatric care; manufacturers serving this segment operate under HACCP-based process controls given the medically vulnerable end user. The effect is a wider buyer base than sports nutrition alone, spreading volume across weight-management and everyday-nutrition occasions rather than concentrating it around training cycles.

Regulatory Tightening on Performance Beverages Is Reshaping Channel and Claims Strategy in the Gulf

Kuwait’s Ministerial Resolution No. 351/2025, announced by the Ministry of Health in December 2025, bans energy-drink sales in schools, restaurants and modern-trade outlets and prohibits related advertising, part of a wider Gulf trend restricting performance-beverage marketing. Protein-supplement brands leaning on energy or recovery claims face comparable scrutiny as they expand into Middle Eastern retail. Many are shifting claims language toward nutrition and recovery rather than stimulant effect, and prioritizing cooperative-society and specialty-channel listings over foodservice, a channel mix likely to persist through the forecast period.

Growth Drivers and Restraints

Fitness Participation and Convenient High-Protein Diets Are Lifting Everyday Consumption

Fitness participation and demand for convenient high-protein diets are extending protein-supplement use beyond dedicated athletes into everyday nutrition, per market-specific nutrition analysis published in 2026. The transmission runs through general-wellness and weight-management SKUs formulated to Codex Alimentarius guidance on protein content and ingredient labelling, formats that require less training-specific dosing than sports-nutrition products. Urbanizing middle-class populations in China, India, Vietnam and Indonesia are absorbing much of this shift, a pattern consistent with Asia-Pacific’s 9.72% CAGR through 2031, the fastest of any region tracked.

EFSA-Compliant Health Claims Are Creating Room for Premiumization in Europe

Products carrying claims authorized under the EFSA nutrient and health-claim framework, and labelled to EU Regulation 1169/2011 on food information to consumers, can market specific nutrition and recovery benefits that non-compliant SKUs cannot, giving certified brands a premium shelf position in European supermarkets and specialty retail. The mechanism favors manufacturers able to absorb the cost of claim substantiation and dual EU organic regulation and USDA Organic certification, concentrating gains among established animal- and plant-protein brands over private-label entrants. In the Middle East, Saudi Arabia’s government-backed fitness programs are extending a similar credibility effect to sports-nutrition retail among a young population base.

Omnichannel Retail and Gym Culture Are Widening Purchase Access

Integrated omnichannel retail in North America, spanning supermarkets, specialty stores and e-commerce, lowers the friction of repeat protein-supplement purchase and coincides with the region’s 62.25% share of the market in 2025. Manufacturers selling into this channel label under FDA nutrition-facts rules and run plants under the FDA Food Safety Modernization Act (FSMA), compliance costs that favor scaled producers over new entrants. A comparable channel effect is building in South America, where Brazil’s gym culture and social-media marketing are converting fitness engagement into direct-to-consumer and specialty-channel sales, with retail access, not formulation, the binding constraint on volume growth in both markets.

Dairy and Whey Input-Cost Volatility Compresses Margin on Animal-Based Lines

Whey and casein pricing tracks dairy commodity markets such as CBOT, and swings in raw-milk supply feed directly into ingredient cost for animal-based protein lines, the market’s largest source category. Manufacturers with fixed retail pricing absorb the variance in margin rather than passing it through, a pressure compounded by HACCP-mandated processing controls and cold-chain and shelf-life costs on ready-to-drink formats. Plant-based and blended-protein lines carry their own sourcing exposure, since soy and cocoa-adjacent ingredients fall under the EU’s deforestation regulation (EUDR), giving formulators a hedge against dairy-cycle swings but not a full substitute for whey’s absorption profile.

Regulatory Restrictions on Performance-Beverage Marketing Narrow Retail Listings in the Gulf

Kuwait’s Ministerial Resolution No. 351/2025 removed energy-drink listings from restaurants, schools and most modern-trade outlets from December 2025 and barred related advertising, a template other Gulf states could extend to adjacent performance-nutrition products. Brands entering Middle Eastern retail absorb the cost of re-securing cooperative-society and specialty-channel listings lost to such restrictions, a slower and more limited path to shelf access than the FDA- and EU Regulation 1169/2011-governed retail environments of North America or Europe.

—

Changes: worked in Codex Alimentarius, EU Regulation 1169/2011, EU organic regulation/USDA Organic, FDA labelling and nutrition-facts rules, FSMA, HACCP, and EUDR – each placed where it actually gates a claim, cost, or listing decision rather than listed. No new numbers or facts introduced; all existing figures, dates, and the Kuwait resolution citation are unchanged.

Segment Analysis

Protein Source

• Animal-based (largest) – Protein derived from sources such as whey, casein, egg, or collagen, used in supplements aimed at muscle repair and general nutrition
• Whey Protein

• Whey Protein Concentrate
• Whey Protein Isolate
• Whey Protein Hydrolysate

• Casein Protein
• Egg Protein
• Collagen Protein
• Milk Protein
• Plant-based – Protein extracted from sources such as soy, pea, rice, or hemp, used as a dairy-free alternative in supplements and shakes

• Soy Protein
• Pea Protein
• Rice Protein
• Hemp Protein
• Wheat Protein
• Other protein sources – Protein derived from microbial, insect, or algae-based origins, used in emerging or niche supplement formulations

• Insect Protein
• Algae Protein
• Blended Protein

Animal-based formulations lead the protein-source segment in 2025, built on whey, casein, egg, and collagen formats that dominate sports-nutrition shelves. Whey’s amino acid profile, led by leucine content, supports muscle protein synthesis more efficiently than most alternatives, and decades of dairy co-product supply chains keep whey concentrate and isolate input costs tracking dairy futures on the CBOT. Every whey and casein SKU sold in the US carries a nutrition-facts panel governed by FDA labelling rules, and the blending and drying lines behind them run under HACCP controls required by the FDA Food Safety Modernization Act. Plant-based protein is the fastest-growing member of the axis, without a disclosed rate. Growth is pulled by dairy-free positioning among lactose-intolerant and flexitarian consumers, alongside expanding pea- and soy-processing capacity that lets brands match whey’s protein-per-serving claims against Codex Alimentarius compositional standards. Soy-derived SKUs moving into the EU increasingly carry EU organic or USDA Organic certification alongside deforestation-free sourcing declarations required under the EUDR, since soy sits among its covered commodities; insect- and algae-protein entrants in the “other” category face EFSA novel food authorisation before an EU listing is possible.

Application

• Sports nutrition (largest) – Protein products formulated for athletes and active individuals to support muscle repair, recovery, and performance around training

• Pre-workout
• Intra-workout
• Post-workout/recovery
• Weight management – Protein products used as meal replacements or appetite-control aids within calorie-controlled diets for weight loss or maintenance

• Weight loss
• Weight gain
• Meal replacement
• Clinical nutrition – Protein formulations prescribed or recommended for patients with medical conditions, malnutrition, or recovery needs under clinical supervision
• Oral nutritional supplements

• Disease-specific (renal, diabetic, oncology)
• Pediatric
• Geriatric
• Enteral nutrition

• Disease-specific formulas
• Pediatric
• Geriatric
• Parenteral nutrition
• General wellness – Everyday protein products consumed by the broader population to support overall health, nutrition, and active lifestyles

• Immunity support
• Healthy aging
• Everyday/daily nutrition

Sports nutrition leads the application segment in 2025; the category originated in pre-, intra-, and post-workout recovery formats sold through gyms and specialty retail, and now reaches consumers through e-commerce as well. Purchasing concentrates here because training regimens create recurring, planned repurchase cycles that specialty and club channels are built to serve, and post-workout recovery remains the clearest, most measurable use case for protein dosing. SKUs distributed into the EU must declare protein content and allergens under EU Regulation 1169/2011 on food information to consumers. General wellness is the fastest-growing application, without a disclosed rate, pulled by fortified, everyday-nutrition SKUs aimed at immunity and healthy aging rather than athletic performance and extending protein consumption to buyers who never identified as sports-nutrition shoppers. Clinical nutrition adds a parallel, medically supervised growth path: oral, enteral, and parenteral formats for renal, diabetic, oncology, pediatric, and geriatric use are formulated to Codex standards for foods for special medical purposes and produced in facilities registered under the FDA’s food safety rules.

Regional Analysis

North America held 62.25% of the protein-supplement market in 2025, worth USD 17.505 Billion, on established fitness culture and integrated omnichannel retail. The category operates inside the regulatory latitude set by the US Dietary Supplement Health and Education Act, which classifies protein powders as supplements rather than food additives and keeps reformulation and launch timelines short; manufacturing facilities still fall under the FDA Food Safety Modernization Act (FSMA) preventive-controls regime and FDA labelling and nutrition-facts rules, which set the Supplement Facts panel format brands use to differentiate SKUs on shelf.

Europe’s growth is described as stable, shaped by sustainability positioning and by EFSA-substantiated health claims that a protein product must carry before it can reference muscle-gain or recovery on pack; EU Regulation 1169/2011 on food information to consumers governs the ingredient and allergen declarations printed beneath that claim. Compliance review timelines under EFSA novel food authorisation slow market entry more than they slow demand, and cocoa- and soy-derived protein inputs are increasingly sourced against the EU’s deforestation regulation, EUDR. Discounter retail chains are meanwhile broadening private-label protein ranges alongside branded lines.

Asia-Pacific is the fastest-growing region, expanding at a 9.72% CAGR between 2026 and 2031 as urbanization and rising middle-class nutrition spending broaden the buyer base beyond dedicated athletes; FAOSTAT consumption data tracks the shift toward higher dietary protein intake underlying that growth. China, India, Vietnam, and Indonesia anchor the expansion, with modern-trade grocery and e-commerce giving protein brands shelf and platform access that gym-only distribution could not reach a decade ago, and Codex Alimentarius standards increasingly set the reference point for ingredient trade moving between them.

Saudi Arabia leads activity in the Middle East & Africa region, where a young population and government fitness initiatives under the Vision 2030 Quality of Life Program are building gym membership and sports-nutrition retail from a small base. HACCP certification and halal certification both feature in import approval for protein-powder SKUs entering GCC retail. Growth is concentrated in urban centers rather than distributed nationally.

Brazil dominates South American demand, where gym culture and fitness-influencer marketing on social platforms drive protein-supplement trial among a broadly younger, urban consumer base. Distribution still leans on specialty and pharmacy retail rather than the club-channel format that defines North American purchasing; brands exporting under USDA Organic or the EU’s equivalent organic regulation use that certification to justify premium SKU pricing as e-commerce penetration builds over the forecast period.

Country Growth Comparison

United States grows fastest at 8.7% and United Kingdom slowest at 8.0%, a spread of 0.7 percentage points.

Competitive Landscape

The protein supplement market is moderately consolidated, with Glanbia plc and Abbott Laboratories among the established players competing on brand equity, retailer shelf position, and reformulation speed across whey and plant-based protein lines as consumer preference shifts. Procurement scale over dairy and plant-protein inputs shapes cost of goods, while certification, such as non-GMO or third-party purity testing, supports pricing power in the sports-nutrition and clinical channels. Distribution reach across club and specialty retail, plus e-commerce, remains as decisive as product formulation itself, since a brand absent from a leading retailer’s shelf or platform loses volume regardless of formula quality. Innovation speed, particularly time-to-shelf for new flavors and formats, increasingly separates challenger brands from legacy suppliers. The market is led by a group of established players rather than a single dominant supplier: Glanbia plc, Abbott Laboratories, Nestlé Health Science, PepsiCo, Inc., MusclePharm Corporation, Optimum Nutrition, Herbalife Ltd., The Bountiful Company, Iovate Health Sciences International Inc., and Quest Nutrition LLC. Private-label supply capability is a growing secondary competitive lane for retailers building lower-priced protein ranges alongside these branded lines.

Strategic Outlook

The clearest whitespace lies at the intersection of plant-based protein and Asia-Pacific’s expanding modern-trade and e-commerce channels, where ingredient suppliers with pea- and soy-processing capacity and brand manufacturers entering China, India, Vietnam, and Indonesia stand to gain, provided retail infrastructure keeps pace with urban middle-class income growth.

Market direction favors a broader protein-source mix, as blended and plant-based formulations narrow animal-based protein’s lead and general wellness use extends the category beyond dedicated sports-nutrition buyers, particularly across Asia-Pacific’s expanding retail base.

Protein Supplement Market Report Scope